Vertex Pharmaceuticals Incorporated
DNA-PK INHIBITORS

Last updated:

Abstract:

The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Status:
Application
Type:

Utility

Filling date:

17 Sep 2020

Issue date:

11 Mar 2021